JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gambling, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gambling, D.
Related Collections
Right arrow Postanesthetic Care Unit
Right arrow Regional Anesthesia
Right arrow Pain
Right arrow Pharmacology

Anesth Analg 2005;100:1065-1074
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000145009.03574.78


PAIN MEDICINE

A Comparison of DepodurTM, a Novel, Single-Dose Extended-Release Epidural Morphine, with Standard Epidural Morphine for Pain Relief After Lower Abdominal Surgery

David Gambling, MB, BS, FRCPC*, Thomas Hughes, MD{dagger}, Gavin Martin, MD{ddagger}, William Horton, MD§, Garen Manvelian, MD|| for the Single-Dose EREM Study Group

*Sharp Mary Birch Hospital for Women, San Diego, California; {dagger}Woodland Memorial Hospital, Woodland, California; {ddagger}Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina; §Progressive Research, LLC, Greenville, South Carolina; and ||SkyePharma, Inc., San Diego, California

Address correspondence and reprint requests to David Gambling, MB, BS, FRCPC, Sharp Mary Birch Hospital for Women, Department of Anesthesiology (Second Floor), 3003 Health Center Dr., San Diego, CA 92123. Address e-mail to dgamb{at}san.rr.com.

In this randomized, controlled, dose-ranging study, we evaluated the analgesic efficacy of a novel single-dose extended-release epidural morphine (DepodurTM) in patients undergoing lower abdominal surgery. Five-hundred-forty-one patients were randomly assigned to one of six epidural treatments administered approximately 30 min before surgery. The 6 treatments were 5 mg of standard epidural morphine sulfate (MS) (active comparator); 5 mg of single-dose extended-release epidural morphine (EREM) (dose control); and 10, 15, 20, and 25 mg of single-dose EREM. The main study objective was to assess the efficacy of single-dose EREM 10, 15, 20, or 25 mg versus single-dose EREM 5 mg for the management of postoperative pain. This was done by plotting a linear dose-response relationship to assess postoperative IV patient-controlled analgesia (PCA) fentanyl consumption for breakthrough pain for 48 h after surgery. Secondary safety and efficacy analyses compared the 10-, 15-, 20-, and 25-mg single-dose EREM groups with the 5-mg single-dose EREM group and compared each single-dose EREM group with 5 mg of MS. As shown by the dose-response relationship, there was a dose-related reduction in the use of postoperative IV fentanyl through 48 h (estimated slope, –22.2; P = 0.0002). Patients treated with 10, 20, and 25 mg of single-dose EREM used significantly less IV fentanyl (mean ± sd: 995 ± 987 µg, P = 0.0446; 972 ± 982 µg, P = 0.0221; and 683 ± 620 µg, P < 0.0001, respectively) through 48 h after surgery compared with the 5-mg single-dose EREM group (1218 ± 894 µg). At 48 h postdose, significantly more single-dose EREM patients (13%) than MS patients (2%) had required no IV fentanyl (P < 0.01). Although all treatment groups had access to PCA fentanyl and there was more frequent PCA fentanyl use in the MS group, patients in the single-dose EREM 15, 20, and 25 mg groups reported significantly lower pain-intensity scores and greater satisfaction with their pain relief. Overall, single-dose EREM was well tolerated, with 97% of adverse events rated as mild to moderate. As expected, the adverse events reported were consistent with those of other epidural opioids (i.e., nausea, vomiting, pruritus, and hypotension). In conclusion, this controlled study demonstrated that single-dose EREM can provide up to 48 h of postoperative analgesia, but supplementation for breakthrough pain is still required in most patients. Within the context of this study, the side effect profile of single-dose EREM was acceptable and predictable.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
R. J. N. Mhuircheartaigh, R. A. Moore, and H. J. McQuay
Analysis of individual patient data from clinical trials: epidural morphine for postoperative pain
Br. J. Anaesth., December 1, 2009; 103(6): 874 - 881.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
E. R. Viscusi, D. R. Gambling, T. L. Hughes, and G. Z. Manvelian
Pharmacokinetics of extended-release epidural morphine sulfate: Pooled analysis of six clinical studies
Am. J. Health Syst. Pharm., June 1, 2009; 66(11): 1020 - 1030.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. Carvalho
Respiratory Depression After Neuraxial Opioids in the Obstetric Setting
Anesth. Analg., September 1, 2008; 107(3): 956 - 961.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
C. Vaughan
Development and implementation of a process to ensure safe use of morphine sulfate extended-release liposome injection
Am. J. Health Syst. Pharm., March 1, 2008; 65(5): 458 - 461.
[Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
M. N. Macias, T. G. Hall, and J. Ostlund
Extended-release epidural morphine and postoperative nausea or vomiting
Am. J. Health Syst. Pharm., February 1, 2008; 65(3): 200 - 200.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. Carvalho, L. M. Roland, L. F. Chu, V. A. Campitelli III, and E. T. Riley
Single-Dose, Extended-Release Epidural Morphine (DepoDurTM) Compared to Conventional Epidural Morphine for Post-Cesarean Pain
Anesth. Analg., July 1, 2007; 105(1): 176 - 183.
[Abstract] [Full Text] [PDF]


Home page
J Am Acad Orthop SurgHome page
T. T. Horlocker, S. L. Kopp, M. W. Pagnano, and J. R. Hebl
Analgesia for total hip and knee arthroplasty: a multimodal pathway featuring peripheral nerve block.
J. Am. Acad. Ortho. Surg., March 1, 2006; 14(3): 126 - 135.
[Abstract] [Full Text] [PDF]


Home page
J Am Board Fam MedHome page
R. Sinatra
Opioid Analgesics in Primary Care: Challenges and New Advances in the Management of Noncancer Pain
J Am Board Fam Med, March 1, 2006; 19(2): 165 - 177.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. R. Viscusi
Emerging Techniques in the Management of Acute Pain: Epidural Analgesia
Anesth. Analg., November 1, 2005; 101(5S_Suppl): S23 - 29.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2005 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2005 by the International Anesthesia Research Society.